Wegovy 0.5mg flextouch 1 pen
Novo Nordisk
SKU: 55755
Wegovy (0.5mg) is a once-weekly, prefilled injection pen—FlexTouch®—designed to support sustainable weight loss and maintenance, in conjunction with a reduced-calorie diet and increased physical activity. It belongs to the class of GLP‑1 receptor agonists, mimicking the natural hormone GLP‑1 to help control appetite and enhance feelings of fullness.
Benefits:
- Aids significant weight loss and long-term weight control in adults with obesity (BMI ≥ 30 kg/m²) or overweight individuals (BMI ≥ 27 kg/m²) with associated health conditions.
- Helps reduce the risk of serious heart-related events in adults with cardiovascular disease.
- Approved for weight management in adolescents aged 12 and older with obesity (weight over 60 kg), when lifestyle adjustments alone are insufficient.
Main Ingredient & Its Benefits:
- Semaglutide: A synthetic GLP‑1 agonist that promotes satiety, reduces appetite, slows gastric emptying, supports weight reduction, and metabolic improvements.
Benefits:
- Aids significant weight loss and long-term weight control in adults with obesity (BMI ≥ 30 kg/m²) or overweight individuals (BMI ≥ 27 kg/m²) with associated health conditions.
- Helps reduce the risk of serious heart-related events in adults with cardiovascular disease.
- Approved for weight management in adolescents aged 12 and older with obesity (weight over 60 kg), when lifestyle adjustments alone are insufficient.
Main Ingredient & Its Benefits:
- Semaglutide: A synthetic GLP‑1 agonist that promotes satiety, reduces appetite, slows gastric emptying, supports weight reduction, and metabolic improvements.
Related products
More From Novo Nordisk
Recently Viewed
